NO-NSAIDs: from inflammatory mediators to clinical readouts
about
O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studiesOverexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitorsIntra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donationChemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.An evidence-based update on nonsteroidal anti-inflammatory drugs.Modulation of prostaglandin activity, part 1: prostaglandin inhibition in the management of nonrheumatologic diseases: immunologic and hematologic aspects.Nitroparacetamol (NCX-701) and pain: first in a series of novel analgesics.Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of ω-3-polyunsaturated fatty acids.Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
P2860
Q28210989-92D870B5-4B78-40E6-AC91-B85EC9ACF665Q33584254-A3F2D331-7C0B-4FFA-9584-A9F8BFB801AEQ33647185-999C6C2B-DB67-4FAF-A838-E7DF1B2047ADQ35638851-EC55E54A-A87F-49B5-94DA-532A500CD97BQ35758411-FABC8F6C-DDD9-4900-A25B-9F8D7C600B64Q36831852-FC706B0B-EA60-471C-A9F5-36EADB0021B7Q36951251-3CC03318-5D9D-4025-B149-62222626C4ECQ37227654-147837FC-DB06-4F04-B696-95399475C6ABQ37278027-385360D6-38DC-43F4-AD64-083C00CFDE79Q37960620-4425DA3E-A007-48D3-9771-A4F2B2977E78Q41113531-2D694FA9-4264-438F-B45B-8C346D9A18D1Q51767077-78BE1EA7-B68D-48DF-AF8B-BE62252FCEF4
P2860
NO-NSAIDs: from inflammatory mediators to clinical readouts
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NO-NSAIDs: from inflammatory mediators to clinical readouts
@ast
NO-NSAIDs: from inflammatory mediators to clinical readouts
@en
NO-NSAIDs: from inflammatory mediators to clinical readouts
@nl
type
label
NO-NSAIDs: from inflammatory mediators to clinical readouts
@ast
NO-NSAIDs: from inflammatory mediators to clinical readouts
@en
NO-NSAIDs: from inflammatory mediators to clinical readouts
@nl
prefLabel
NO-NSAIDs: from inflammatory mediators to clinical readouts
@ast
NO-NSAIDs: from inflammatory mediators to clinical readouts
@en
NO-NSAIDs: from inflammatory mediators to clinical readouts
@nl
P3181
P1476
NO-NSAIDs: from inflammatory mediators to clinical readouts
@en
P2093
Elisabetta Antonelli
P304
P3181
P356
10.2174/187152806776383161
P407
P577
2006-04-01T00:00:00Z